Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke

Key facts

Sponsor

Peking University People's Hospital

Principal Investigator

Xiao-Hui Zhang, MD

eking University Institute of Hematology, Peking University People's Hospital

Enrollment

500 enrolled

Eligibility

All sexes

Timeline

2025 – 2036

Collaborators

Jiangsu province hospital of TCM · Army Medical University, China · Henan Cancer Hospital · Ningbo University Affiliated People's Hospital · West China Hospital · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Zhejiang University · The Second Hospital Of Hebe Medical University · Kunming Medical University Second Affiliated Hospital · Shanghai Zhongshan Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Huazhong Science & Technology Shanxi Baiqiu En Hospital · NORTHERN JIANGSU PEOPLE'S HOSPITAL 1900 · Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology · Xuzhou Medical University Affiliated Hospital of Huaian · Affiliated Hospital of Fujian Medical University, Xiehe Branch · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · First Affiliated Hospital of Guangxi Medical University · The Third Xiangya Hospital of Central South University · Second Xiangya Hospital of Central South University · Xiangya Hospital of Central South University · Qilu Hospital of Shandong University · Southern Medical University - Southern Hospital · The Second Hospital of Hebei Medical University · The First Hospital Affiliated to University of Science and Technology of China · The First Affiliated Hospital of Nanchang University · First Affiliated Hospital of Xinjiang Medical University · North China University of Science and Technology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Autoimmune thrombocytopenia

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07559331
  High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia
  Shandong University
• RECRUITINGPHASE2NCT07362238
  Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGPHASE2NCT07362199
  Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGEARLY PHASE1NCT07441525
  UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
• RECRUITINGPHASE2NCT07234019
  Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGPHASE2NCT07297563
  Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
  Institute of Hematology & Blood Diseases Hospital, China
• RECRUITINGPHASE2NCT07294365
  A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)
  Dizal Pharmaceuticals
• RECRUITINGPHASE2NCT07104565
  Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
  Incyte Corporation

See all trials for Autoimmune thrombocytopenia →